IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. The disease recurrent rate is relatively high resulted in poor 5-year survival in advanced HCC. Cancer stem cells (CSCs) have been considered to be one of the main mechanisms for chemoresistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei-Chieh, Tung, Shiao-Lin, Chen, Yao-Li, Chen, Po-Ming, Chu, Pei-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977745/
https://www.ncbi.nlm.nih.gov/pubmed/29848298
http://dx.doi.org/10.1186/s12885-018-4529-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977745/
https://www.ncbi.nlm.nih.gov/pubmed/29848298
http://dx.doi.org/10.1186/s12885-018-4529-9

Ejemplares similares